Envoy Group Corp (ENVV) is Pleased to Introduce the Core Line of Louis XIV Energy Drinks


VALENCIA, California, Dec. 11, 2015 (GLOBE NEWSWIRE) – (ENVV) Envoy Group announced (December 7th, 2015) it was moving into the $40 Billion Energy drink market with the exclusive distribution rights for the full family of Louis XIV Energy Drinks. Previously only available in Europe, Louis XIV Energy drinks have an outstanding elegant look and use only the finest ingredients to produce a product of optimal quality.


Envoy initially plans to market four Louis XIV energy drinks:


Louis XIV – Energy: the top selling product in the Louis XIV line is a balance of high energy and smooth taste. Charged with personality, this distinctive energy drink possesses a flavorful citric base with aromas of vanilla, caramel and raspberry. http://www.louisxivenergy.com/en/louis_xiv_energy


Louis XIV – Sugar Free: This is a full bodied energy drink with all the taste and none of the sugar. Full of life, this drink complements those seeking a healthier alternative to the present market lineup of high sugar-content energy drinks. http://www.louisxivenergy.com/en/louis_xiv_sugar_free


Louis XIV – 24 Carat Gold: The most exclusive energy drink in the world, this is the one and only energy drink worldwide with real 24 carat gold flakes. The 24 Carat edition creates an incredible synergy with the health effects of this rare and mystic metal and the highly effective energy refresher. http://www.louisxivenergy.com/en/louis_xiv_energy_24k


Louis XIV – Glow: The glow edition brings incredible fun and life to the nightclub and party scene. With a special additive that glows when exposed to UV light, the smooth and tasty Glow edition truly lights up any mixed drink that it enhances. http://www.louisxivenergy.com/en/louis_xiv_energy_glowAll the Louis XIV Energy Drinks are infused with Vitamins B2, B3, B5, B6 and B12. Each product is crafted to produce an ideal balance of high energy and incredible taste. Each product acts as a perfect refresher, a sports drink or as a complement to a variety of mixed drinks.


Envoy is excited to be bringing this premium line of energy drinks to the very active multibillion-dollar market. Further Louis XIV drinks and lifestyle products will be strategically introduced in 2016.


For further information please visit our website at: www.envoygroupcorp.com

Louis XIV website link: http://www.louisxivenergy.com/en/

Facebook: www.facebook.com/louisxivenergy/


Envoy Group Corp.
28494 Westinghouse Place
Suite 213
Valencia, CA 91355


Corporate Contact:
Harp Sangha
Chairman, Interim CEO & CFO
Email:   hsangha@envoygroupcorp.com

Investor Relations Contact:
Stuart Smith, Investor Relations
Tel:        1-512-267-2430
Email:   ssmith@smallcapvoice.com



Safe Harbor Statements
Certain information contained in this news release constitutes “forward-looking statements” as such term is used in applicable United States and Canadian laws. Generally, these forward-looking statements can be identified by the use of forward-looking terminology such as “expects” or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “estimates”, “intends” or “believes”, or that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur”, or “be achieved”. Forward-looking statements are based on the opinions and estimates of management as of the date such statements are made, and are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements. Many of these factors are beyond the Company’s ability to control or predict. Important factors that may cause actual results to differ materially and that could impact the Company and the statements contained in this news release can be found in the Company’s filings with the SEC. Such risks and other factors include, among others, the ability to locate and acquire suitable interests in alternative medicine manufacturing operations on terms acceptable to the Company, the availability of financing on acceptable terms, accidents, labor disputes, acts of God and other risks of the alternative medicine industry including, without limitation, delays in obtaining governmental approvals or permits, title disputes or claims limitations on insurance coverage. The Company believes that the expectations reflected in the forward-looking statements included in this news release are reasonable; however, no assurance can be given that these expectations will prove to be correct, and such forward-looking statements should not be unduly relied upon. The Company assumes no obligation to update or supplement any forward-looking statements whether as a result of new information, future events or otherwise.